Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Edgewater Place Capital is an Australian investment firm dedicated to supporting purposeful businesses. It focuses on early growth, scale-up, and middle-market stage companies, aiming to deliver above-market returns while creating positive social and environmental impact. The firm manages investments across a global portfolio, particularly in Oceania.
Edgewater Place Capital invests between $500,000 and $5 million in high-growth and middle-market companies. Their focus includes sectors such as consumer goods, healthcare, climate, and edtech, with an emphasis on long-term thematic trends like organic foods and environmental sustainability.
Notable investments include Seventh Generation, which was sold to Unilever for approximately $770 million, and Vapogenix, a clinical stage company developing non-opioid analgesics for pain relief.
Edgewater Place Capital invests in Seed+ (Extension), Series A, and Growth Equity stages.
The firm focuses on socially-responsible businesses in sectors like consumer, healthcare, climate, and edtech, targeting long-term thematic trends.
Investments typically range from $500,000 to over $5 million.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.